A new report about the use of medical data to develop AI in Poland

Topic:

Ardigen contributed to the report “The use of medical data to develop AI and to conduct scientific research in Poland” published by the lawyers of the law firm Domański Zakrzewski Palinka on behalf of the Coalition of AI in Health. ” The report was created on the basis of gaining insight into the challenges that will arise in connection with the technological revolution and the rapid development of artificial intelligence in the area of medical research.

 

Conclusions of the report will be useful when constructing the policy for the development of artificial intelligence in the healthcare sector, as well as in legislative, regulatory and administrative work on improving access to and quality of medical data in Poland.

 

The prepared analysis answers the following questions:

  1. What are the legal conditions, especially opportunities and barriers, related to access to medical data in Poland to conduct scientific research, including research and development works and development of AI algorithms?;
  2. What actions (legislative, regulatory and other) should be taken to increase access to and quality of medical data in the context of scientific research and AI development?

 

The coalition was established to bring together leading national and global entities interested in issues related to the development and use of artificial intelligence, possessing extensive knowledge and competence in this area.

 

The group works to identify and implement educational, technical, organizational and regulatory activities that will maximize the benefits of implementing solutions based on artificial intelligence in the Polish healthcare sector. In particular, increasing the effectiveness of patient treatment and access to healthcare services , while ensuring adequate protection of their rights and freedoms.

 

Our experts, Dr. Michał Warchoł, Director of AI Labs, and Bożena Augustyn, Clinical Operations Manager, were invited to join the group of AI Champions to support the discussion about issues raised in the report.

 

Current information about the coalition, as well as a form to support the manifesto can be found at http://www.aiwzdrowiu.pl/.

You might be also interested in:

Blog cover for Ardigen publication on ARDisplay-I and MHC ligand identification in Molecular & Cellular Proteomics
New publication in MCP: Improving MHC ligand identification with machine learning and optimized isolation
Fluorescence microscopy image of cells stained with multiple Cell Painting dyes showing cellular organelles in green, blue, and pink, overlaid with Ardigen brand graphic elements indicating phenomics data in durg discovery
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Abstract network visualization representing AI-driven integration of biological data and knowledge graphs for target identification in drug discovery.
Target Identification: From Poor Data to Quality Predictions
Abstract data streams representing data sourcing in pharmaceutical research and AI drug discovery
What Are Common Data Sourcing Patterns in Pharmaceutical Research (part 3)

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!